Cinnamamide derivatives with 4-hydroxypiperidine moiety enhance effect of doxorubicin to cancer cells and protect cardiomyocytes against drug-induced toxicity through CBR1 inhibition mechanism-Reference-Cited by-同舟云学术

Cinnamamide derivatives with 4-hydroxypiperidine moiety enhance effect of doxorubicin to cancer cells and protect cardiomyocytes against drug-induced toxicity through CBR1 inhibition mechanism

Published:2022-09 Issue: Volume:305 Page:120777
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Koczurkiewicz-Adamczyk Paulina,Gąsiorkiewicz Bartosz,Piska Kamil,Gunia-Krzyżak Agnieszka,Jamrozik Marek,Bucki Adam,Słoczyńska Karolina,Bojdo Patrycja,Wójcik-Pszczoła Katarzyna,Władyka Benedykt,Kołaczkowski Marcin,Pękala Elżbieta

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference47 articles.

1. Antitumour anthracyclines: progress and perspectives;Martins-Teixeira;ChemMedChem,2020

2. Essential medicines for cancer: WHO recommendations and national priorities;Robertson;Bull. World Health Organ.,2016

3. Doxorubicin-induced chronic dilated cardiomyopathy-the apoptosis hypothesis revisited;Kankeu;J. Mol. Med. (Berl).,2017

4. Doxorubicin induces wide-spread transcriptional changes in the myocardium of hearts distinguishing between mice with preserved and impaired cardiac function;Stamm;Life Sci.,2021

5. Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management;Rawat;Biomed. Pharmacother.,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardioprotective effect of Cinnamamide derivative compound 10 against myocardial ischemia-reperfusion through regulating cardiac autophagy via Sirt1;Biomedicine & Pharmacotherapy;2024-07

2. Potential Mechanism by which Eriodictyol Protects against Doxorubicininduced Cardiotoxicity based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation;Current Computer-Aided Drug Design;2024-06-05

3. Synergistic anticancer effects of SMYD2 inhibitor BAY-598 and doxorubicin in non-small cell lung cancer;Heliyon;2024-06

4. In vitro evaluation of the reductive carbonyl idarubicin metabolism to evaluate inhibitors of the formation of cardiotoxic idarubicinol via carbonyl and aldo–keto reductases;Archives of Toxicology;2024-01-04

5. In Silico and In Vitro Assessment of Carbonyl Reductase 1 Inhibition Using ASP9521—A Potent Aldo-Keto Reductase 1C3 Inhibitor with the Potential to Support Anticancer Therapy Using Anthracycline Antibiotics;Molecules;2023-04-27